<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Module 14: Lesson 2: Advanced Microbiome Analysis: Beyond Diversity Scores</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #065f46 0%, #059669 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #111;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 38px;
            font-weight: 700;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f8f1;
            color: #059669;
            font-weight: 600;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #2e7d32;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding-bottom: 40px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 14: Advanced Gastrointestinal Integration</p>
            <h1 class="lesson-title">Lesson 2: Advanced Microbiome Analysis: Beyond Diversity Scores</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#sequencing"><span class="section-num">1</span>Sequencing Technologies</a></li>
                <li><a href="#keystone"><span class="section-num">2</span>The Keystone Species</a></li>
                <li><a href="#scfas"><span class="section-num">3</span>SCFA Metabolomics</a></li>
                <li><a href="#endotoxemia"><span class="section-num">4</span>Metabolic Endotoxemia</a></li>
                <li><a href="#ratios"><span class="section-num">5</span>Interpreting Ratios</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between 16S rRNA and Shotgun Metagenomic sequencing for clinical decision-making.</li>
                <li>Evaluate the functional roles of *Akkermansia muciniphila* and *Faecalibacterium prausnitzii* in systemic health.</li>
                <li>Interpret Short-Chain Fatty Acid (SCFA) profiles to assess metabolic and immunological status.</li>
                <li>Identify markers of Metabolic Endotoxemia and their role in chronic systemic inflammation.</li>
                <li>Apply the B.R.I.D.G.E. Methodâ„¢ to translate complex microbiome data into individualized protocols.</li>
            </ul>
        </div>

        <h2 id="sequencing">1. The Evolution of Analysis: 16S vs. Shotgun Metagenomics</h2>
        <p>In the early days of functional medicine, microbiome testing was limited to culture-based methods, which missed nearly <span class="highlight">95% of anaerobic species</span>. Today, we utilize DNA-based sequencing, but not all sequencing is created equal. As an Integrative Practitioner, choosing the right tool is the "Data-Driven Decisions" (D) pillar of the B.R.I.D.G.E. Methodâ„¢.</p>

        <h3>16S rRNA Sequencing</h3>
        <p>This method targets a specific, highly conserved region of the bacterial genome (the 16S ribosomal RNA gene). It acts like a "barcode" for bacteria. While cost-effective, it generally only provides identification down to the <span class="highlight">Genus level</span> and cannot distinguish between specific strains or identify non-bacterial organisms like viruses or fungi.</p>

        <h3>Shotgun Metagenomics</h3>
        <p>Unlike 16S, Shotgun Metagenomics sequences *all* the DNA in a sample. This allows for <span class="highlight">Species and Strain-level identification</span>. More importantly, it provides functional dataâ€”telling us not just who is there, but what they are *doing* (e.g., do they have the genes to produce butyrate or degrade oxalate?).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>16S rRNA Sequencing</th>
                        <th>Shotgun Metagenomics</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Resolution</strong></td>
                        <td>Genus Level</td>
                        <td>Species & Strain Level</td>
                    </tr>
                    <tr>
                        <td><strong>Kingdoms Detected</strong></td>
                        <td>Bacteria & Archaea only</td>
                        <td>Bacteria, Viruses, Fungi, Parasites</td>
                    </tr>
                    <tr>
                        <td><strong>Functional Insight</strong></td>
                        <td>Inferred/Predicted</td>
                        <td>Direct Gene Mapping</td>
                    </tr>
                    <tr>
                        <td><strong>Clinical Utility</strong></td>
                        <td>General Diversity/Screening</td>
                        <td>Complex Chronic Disease/Precision Intervention</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="keystone">2. The Keystone Paradigm: Akkermansia & Faecalibacterium</h2>
        <p>We are moving away from the "Good vs. Bad" bacteria binary. Instead, we focus on <span class="highlight">Keystone Species</span>â€”organisms that exert an outsized influence on the ecosystem's stability. Two species dominate current clinical research: *Akkermansia muciniphila* and *Faecalibacterium prausnitzii*.</p>

        <h3>Akkermansia muciniphila: The Mucosal Sentinel</h3>
        <p>Representing 1-4% of the healthy adult microbiome, *Akkermansia* lives in the mucus layer. It degrades mucin, which paradoxically stimulates the goblet cells to produce *more* mucus, thickening the gut barrier. A 2022 study (n=1,024) found that low levels of *Akkermansia* were strongly correlated with <span class="highlight">insulin resistance and visceral adiposity</span>.</p>

        <h3>Faecalibacterium prausnitzii: The Anti-Inflammatory Powerhouse</h3>
        <p>One of the most abundant bacteria in the healthy human gut, *F. prausnitzii* is a primary producer of butyrate. It also produces a unique protein called <span class="highlight">MAM (Microbial Anti-inflammatory Molecule)</span>, which inhibits the NF-ÎºB pathway, directly reducing intestinal inflammation. Depletion is a hallmark of Crohn's disease and Ulcerative Colitis.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study 1: The Metabolic Plateau</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Client: Sarah, 44 | Presentation: Weight loss resistance, HbA1c 5.8%</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Initial Assessment:</strong> Sarah followed a strict "clean" diet but could not lose weight. Her microbiome analysis via Shotgun Metagenomics revealed *Akkermansia muciniphila* at <0.01% (below detectable limits).</p>
                <p><strong>Intervention:</strong> Utilizing the "Blend Approaches" (B) pillar, we introduced polyphenol-rich extracts (Pomegranate and Cranberry) and a specific prebiotic (FOS) known to cross-feed *Akkermansia*. We avoided high-fat ketogenic dieting, which Sarah had tried, as some studies suggest it may reduce *Akkermansia* if fiber is insufficient.</p>
                <p><strong>Outcome:</strong> After 12 weeks, her *Akkermansia* rose to 1.2%. Sarah reported a spontaneous loss of 8 lbs and her HbA1c dropped to 5.4% without further caloric restriction.</p>
            </div>
        </div>

        <h2 id="scfas">3. SCFA Metabolomics: The Language of the Gut</h2>
        <p>Short-Chain Fatty Acids (SCFAs) are the primary metabolites produced by the fermentation of dietary fiber. They are not just "gut fuel"; they are systemic signaling molecules that enter the bloodstream and influence the brain, liver, and immune system.</p>

        <ul>
            <li><strong>Butyrate:</strong> The primary fuel for colonocytes. It induces <span class="highlight">T-regulatory cells (Tregs)</span>, preventing autoimmunity and overactive immune responses.</li>
            <li><strong>Acetate:</strong> The most abundant SCFA. It travels to the peripheral tissues and plays a role in pH regulation and appetite suppression via central nervous system signaling.</li>
            <li><strong>Propionate:</strong> Involved in gluconeogenesis in the liver and has been shown to reduce cholesterol synthesis and influence satiety hormones like PYY and GLP-1.</li>
        </ul>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">90%</div>
                    <div class="stat-label">Colonocytes' energy from Butyrate</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3:1:1</div>
                    <div class="stat-label">Optimal Acetate:Propionate:Butyrate Ratio</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">42%</div>
                    <div class="stat-label">Reduced risk of T2DM with high SCFAs</div>
                </div>
            </div>
        </div>

        <h2 id="endotoxemia">4. Metabolic Endotoxemia: The LPS Trigger</h2>
        <p>Lipopolysaccharide (LPS) is a structural component of the outer membrane of Gram-negative bacteria. When the gut barrier is compromised ("Leaky Gut"), LPS translocates into the bloodstream, a state known as <span class="highlight">Metabolic Endotoxemia</span>.</p>
        <p>LPS binds to Toll-Like Receptor 4 (TLR4) on immune cells, triggering a cascade of pro-inflammatory cytokines (IL-6, TNF-Î±). This is often the "Root Cause" (R) of the low-grade systemic inflammation seen in Module 9. A 2023 meta-analysis of 56 studies confirmed that serum LPS levels are significantly higher in patients with <span class="highlight">non-alcoholic fatty liver disease (NAFLD)</span> compared to healthy controls (p < 0.001).</p>

        <h2 id="ratios">5. Interpreting Dysbiosis Ratios: The F/B Ratio Myth</h2>
        <p>For years, the Firmicutes-to-Bacteroidetes (F/B) ratio was touted as a definitive marker for obesity. However, advanced analysis shows this is overly simplistic. While an elevated ratio *can* correlate with increased energy harvest from food, the <span class="highlight">diversity within these phyla</span> matters more.</p>
        <p>Instead of just the F/B ratio, practitioners should look for:</p>
        <ul>
            <li><strong>Proteobacteria Overgrowth:</strong> High levels of this phylum (which includes *E. coli* and *Salmonella*) are a signature of an unstable, pro-inflammatory microbiome.</li>
            <li><strong>The Diversity Paradox:</strong> High alpha-diversity is generally healthy, but in cases of Small Intestinal Bacterial Overgrowth (SIBO), "too much of a good thing" in the wrong place causes dysfunction.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ”¬</div>
                <div>
                    <p class="box-label">Case Study 2: Post-Antibiotic Recovery</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Client: James, 29 | Presentation: Brain fog, bloating, and joint pain</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Clinical Situation:</strong> James completed two rounds of broad-spectrum antibiotics for a sinus infection. Six months later, he presented with systemic symptoms. Lab work showed high fecal calprotectin (150 Î¼g/g) and low total SCFAs.</p>
                <p><strong>Microbiome Findings:</strong> Shotgun sequencing showed a "Proteobacteria bloom" (12% of total bacteria) and a complete absence of *F. prausnitzii*.</p>
                <p><strong>Intervention:</strong> Following the "Individualize Care" (I) pillar, we used *Saccharomyces boulardii* to compete with Proteobacteria and introduced partially hydrolyzed guar gum (PHGG) to selectively boost butyrate producers. We avoided aggressive "gut cleanses" which would further deplete his fragile ecosystem.</p>
                <p><strong>Outcome:</strong> Within 8 weeks, joint pain resolved. Repeat testing showed Proteobacteria reduced to <2% and a return of commensal *Faecalibacterium*.</p>
            </div>
        </div>

        <h2 id="clinical">6. Clinical Application: The B.R.I.D.G.E. Approach to Data</h2>
        <p>How do we integrate these complex markers into a cohesive plan? We use the <strong>B.R.I.D.G.E. Methodâ„¢</strong>:</p>
        <ul>
            <li><strong>Blend:</strong> Combine microbiome data with clinical symptoms. Don't treat the paper; treat the person.</li>
            <li><strong>Root Cause:</strong> Is the low *Akkermansia* due to a low-fiber diet, or is it a mediator of the client's high-stress lifestyle (which reduces mucus production)?</li>
            <li><strong>Individualize:</strong> Use specific prebiotics (e.g., HMOs for *Bifidobacteria*, Pomegranate for *Akkermansia*) based on the client's unique deficiencies.</li>
            <li><strong>Data-Driven:</strong> Use Shotgun Metagenomics for complex cases where 16S lacks the necessary resolution.</li>
            <li><strong>Guide:</strong> Educate the client on the "Garden Metaphor"â€”we are weeding (reducing Proteobacteria), seeding (probiotics), and feeding (prebiotics).</li>
            <li><strong>Evolve:</strong> Re-test after 3-4 months. The microbiome is dynamic; your protocol must be too.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why is Shotgun Metagenomics preferred over 16S rRNA sequencing for identifying the functional capacity of the microbiome?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Shotgun metagenomics sequences the entire genome of all organisms present, allowing for the identification of specific genes (e.g., butyrate-producing genes) and providing species/strain-level resolution, whereas 16S only targets one gene and usually only reaches genus-level resolution.</div>
            </div>
            <div class="question-item">
                <p class="question-text">2. A client has high levels of LPS in their blood. Which "Root Cause" GI finding is most likely responsible?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Intestinal permeability ("Leaky Gut"), often coupled with an overgrowth of Gram-negative bacteria (Proteobacteria), which allows the LPS from the bacterial cell walls to translocate into systemic circulation.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Diversity is a marker of health, but <strong>functional capacity</strong> (what the bacteria produce) is a more precise clinical target.</li>
                <li><strong>Keystone species</strong> like *Akkermansia* and *F. prausnitzii* are non-negotiable for metabolic and immune homeostasis.</li>
                <li><strong>SCFAs</strong> act as the "remote controls" for systemic health, influencing everything from blood sugar to brain function.</li>
                <li><strong>Metabolic Endotoxemia</strong> (LPS translocation) is a primary driver of chronic "inflammaging" and metabolic syndrome.</li>
                <li>Advanced analysis requires the <strong>B.R.I.D.G.E. Methodâ„¢</strong> to ensure data is translated into actionable, individualized care.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Cani PD, et al. (2022). "Akkermansia muciniphila: a novel target in obesity and type 2 diabetes." <i>Nature Reviews Endocrinology</i>.</li>
                <li>Sokol H, et al. (2018). "Faecalibacterium prausnitzii is an anti-inflammatory bacterium lacking in Crohn's disease." <i>PNAS</i>.</li>
                <li>Louis P, et al. (2017). "Formation of propionate and butyrate by the human colonic microbiota." <i>Environmental Microbiology</i>.</li>
                <li>Milanese A, et al. (2019). "Microbial abundance dynamics and community structure of the human microbiome." <i>Nature Communications</i>.</li>
                <li>Cani PD, et al. (2007). "Metabolic Endotoxemia Initiates Obesity and Insulin Resistance." <i>Diabetes Journal</i>.</li>
                <li>Human Microbiome Project Consortium (2012). "Structure, function and diversity of the healthy human microbiome." <i>Nature</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Coursework.</p>
        </footer>
    </div>
</body>

</html>